This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2xp3
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
==DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION== | ==DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION== | ||
| - | <StructureSection load='2xp3' size='340' side='right' caption='[[2xp3]], [[Resolution|resolution]] 2.00Å' scene=''> | + | <StructureSection load='2xp3' size='340' side='right'caption='[[2xp3]], [[Resolution|resolution]] 2.00Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2xp3]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2xp3]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XP3 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2XP3 FirstGlance]. <br> |
| - | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> |
| - | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=12P:DODECAETHYLENE+GLYCOL'>12P</scene>, <scene name='pdbligand=B21:5-(2-METHOXYPHENYL)-2-FUROIC+ACID'>B21</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2xp3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2xp3 OCA], [https://pdbe.org/2xp3 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2xp3 RCSB], [https://www.ebi.ac.uk/pdbsum/2xp3 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2xp3 ProSAT]</span></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/PIN1_HUMAN PIN1_HUMAN] Essential PPIase that regulates mitosis presumably by interacting with NIMA and attenuating its mitosis-promoting activity. Displays a preference for an acidic residue N-terminal to the isomerized proline bond. Catalyzes pSer/Thr-Pro cis/trans isomerizations. Down-regulates kinase activity of BTK. Can transactivate multiple oncogenes and induce centrosome amplification, chromosome instability and cell transformation. Required for the efficient dephosphorylation and recycling of RAF1 after mitogen activation.<ref>PMID:15664191</ref> <ref>PMID:16644721</ref> <ref>PMID:21497122</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 21: | ||
==See Also== | ==See Also== | ||
| - | *[[Peptidyl-prolyl cis-trans isomerase|Peptidyl-prolyl cis-trans isomerase]] | + | *[[Peptidyl-prolyl cis-trans isomerase 3D structures|Peptidyl-prolyl cis-trans isomerase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Baker | + | [[Category: Baker L]] |
| - | [[Category: Bryant | + | [[Category: Bryant CJ]] |
| - | [[Category: Davis | + | [[Category: Davis BE]] |
| - | [[Category: Dokurno | + | [[Category: Dokurno P]] |
| - | [[Category: Fromont | + | [[Category: Fromont C]] |
| - | [[Category: Matossova | + | [[Category: Matossova N]] |
| - | [[Category: Moore | + | [[Category: Moore JD]] |
| - | [[Category: Murray | + | [[Category: Murray JB]] |
| - | [[Category: Northfield | + | [[Category: Northfield CJ]] |
| - | [[Category: Nunns | + | [[Category: Nunns C]] |
| - | [[Category: Oldfield | + | [[Category: Oldfield V]] |
| - | [[Category: Potter | + | [[Category: Potter A]] |
| - | [[Category: Ray | + | [[Category: Ray S]] |
| - | [[Category: Richardson | + | [[Category: Richardson CM]] |
| - | [[Category: Robinson | + | [[Category: Robinson D]] |
| - | [[Category: Scrace | + | [[Category: Scrace SF]] |
| - | [[Category: Surgenor | + | [[Category: Surgenor AE]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION
| |||||||||||
Categories: Homo sapiens | Large Structures | Baker L | Bryant CJ | Davis BE | Dokurno P | Fromont C | Matossova N | Moore JD | Murray JB | Northfield CJ | Nunns C | Oldfield V | Potter A | Ray S | Richardson CM | Robinson D | Scrace SF | Surgenor AE
